Rather than constantly thinking about their next meal or fighting cravings, they report being able to stop eating when satisfied. That reported drop in food noise tracks with peptide YYs known role: the hormone reduces food intake and extends fullness after a meal, and combined with cholecystokinin and GLP-1, reinforces the bodys normal post-meal signaling
Retatrutide clinical development and safety information, 2026
These trials established the pharmacokinetic profile showing that weekly injections maintain optimal therapeutic levels while minimizing adverse events
Abdul-Ghani M, Puckett C, Adams J et al (2021) Durability of triple combination therapy versus stepwise addition therapy in patients with new-onset T2DM: 3-year follow-up of EDICT
When people first go on these medications they lose muscle and fat (which is natural), but if they go off of them and gain weight back, its all fat
LY3437943, a novel triple GIP/GLP-1/glucagon receptor agonist for the treatment of type 2 diabetes mellitus